so far , only three patients have received the pioneering therapy - two with a blood cancer called multiple myeloma and one with sarcoma , a connective - tissue cancer , according to a statement from the university of pennsylvania . researchers were able to safely remove , edit and return the cells to patients ' bodies . safety was measured in terms of side effects , and the authors found that there were no serious side effects from the treatment .